Investigating delays in diagnosing venous thromboembolism in different healthcare settings
Official title: Complexity, Incidence, and Costs Related to Delayed Diagnosis of Venous Thromboembolism in Urban and Rural Primary and Urgent Care Settings
Funded at Brigham and Women's Hospital · NIH-11020773 · Data updated 2026-11-12
This study is looking into why some people with blood clots, like pulmonary embolism and deep vein thrombosis, don’t get diagnosed quickly, and it aims to find ways to improve care for everyone, whether they live in cities or rural areas.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brigham and Women's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | September 1, 2024 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| Award (this year) | $500,000 |
| NIH project number | 1R01HS030221-01 |
| Project ID | NIH-11020773 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include adults who are at risk for venous thromboembolism, particularly those seeking care in primary or urgent care settings.
✕Less likely to help
Patients who do not present with symptoms or risk factors for venous thromboembolism may not benefit from this research.
What this research studies
This research focuses on understanding the complexities and costs associated with delayed diagnoses of venous thromboembolism (VTE), which includes conditions like pulmonary embolism and deep vein thrombosis. The study aims to identify the factors contributing to these delays in both urban and rural primary and urgent care settings. By utilizing an electronic clinical quality measure (eCQM) that analyzes electronic health record (EHR) data, the research seeks to quantify the incidence of diagnostic delays and improve the overall quality of care for patients at risk of VTE. The findings could lead to better diagnostic protocols and ultimately enhance patient outcomes.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic accuracy and timeliness for patients at risk of venous thromboembolism, reducing morbidity and healthcare costs.
How similar studies have gone: Previous research has indicated significant delays in VTE diagnosis, suggesting that this approach to improving diagnostic workflows is both relevant and necessary.
Where this research is happening
-
Brigham and Women's Hospital
Boston, United States Active
Researchers
- Principal investigator: Dykes, Patricia C — Brigham and Women's Hospital
- Study coordinator: Dykes, Patricia C
Related research
Other NIH-funded projects on the same topics.
-
Statins to Prevent Cancer-Associated Blood Clots in Cancer Patients
A large study will test whether taking rosuvastatin every day for a year can lower the chance of dangerous blood clots in people with cancer, without raising the risk of bleeding.
-
Optimal use of blood thinners for venous clots in people with cirrhosis
This grant hopes to figure out the safest and most effective way to use oral anticoagulants for adults with cirrhosis who develop venous clots.
-
PET/CT imaging to detect chemotherapy-related vascular harm in young cancer patients
A non-invasive PET/CT scan method using standard care imaging is being tested to identify which pediatric and young adult cancer patients are at higher risk of blood clots from chemotherapy.
-
Statins to Prevent Cancer-Associated Blood Clots in Cancer Patients
A large clinical trial will test whether taking rosuvastatin daily for a year helps prevent dangerous blood clots in people with newly diagnosed or relapsed cancer who aren’t already getting anticoagulants.
-
BCOR's role in blood clot risk and liver genetics
A Johns Hopkins-led study is exploring how a human gene, BCOR, may control liver-produced clotting factors to influence venous blood clots.
-
Personalized risk-prediction for hospital-acquired blood clots in adults
A real-time risk model helps doctors identify adults in the hospital who are at higher risk of developing blood clots so they can prevent them safely.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.